Pradaxa is another example of a new drug gone bad. Marketed as the latest and most improved version of anti-clotting medications, it turns out to be much riskier that well-established drugs already on the market. Since 2010, Pradaxa has been prescribed by physicians to prevent stokes, particularly in elderly people who have an irregular heartbeat. A devastating acknowledgment, however, by the German manufacturer of Pradaxa, Boehringer Ingelheim, notes that hundreds of deaths since 2010 may be the result of uncontrollable internal bleeding caused by Pradaxa.
The Judicial Panel on Multidistrict Litigation (JPML) has created a new MDL for Wright Medical “Conserve” hip implant cases in the United States District Court of Georgia for the Northern District. Plaintiffs’ counsel argued that more than 200 Wright patients have reported adverse events associated with the Wright Conserve system hip implants. Further, the defects alleged in the Wright Conserve hip are similar to those alleged in the DePuy ASR Device, which has a pending MDL in the Northern District of Ohio.
Transvaginal mesh or slings are common devices used to help women cope with pelvic organ prolapse and stress urinary incontinence. One of the more popular devices is the Novasilk mesh, manufactured by Coloplast. The Novasilk mesh is a transvaginal mesh used to help correct pelvic organ prolapse by reinforcing the weakened tissue and stabilizing the vaginal wall. Introduced to the market in 2005, Novasilk was not required to undergo testing based on its similarity to an already approved device by the FDA. Novasilk is a synthetic mesh made of polypropylene, a lightweight material that is less stiff than previous mesh designs. Similar to other mesh products, this product also does not come without the dangerous risks of erosion and exposure.